CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,376,406 | +61.5% | 1,225,047 | +31.9% | 0.00% | +50.0% |
| Q2 2023 | $20,670,972 | +22.9% | 929,032 | +19.6% | 0.00% | 0.0% |
| Q1 2023 | $16,822,824 | -23.6% | 776,677 | -28.4% | 0.00% | -33.3% |
| Q4 2022 | $22,032,776 | -25.7% | 1,084,824 | -6.2% | 0.00% | -25.0% |
| Q3 2022 | $29,641,000 | +28.9% | 1,155,996 | +19.5% | 0.00% | +33.3% |
| Q2 2022 | $22,996,000 | +23.8% | 966,982 | +17.2% | 0.00% | 0.0% |
| Q1 2022 | $18,577,000 | +33.8% | 824,894 | +17.7% | 0.00% | +50.0% |
| Q4 2021 | $13,879,000 | -4.2% | 701,009 | -4.8% | 0.00% | 0.0% |
| Q3 2021 | $14,490,000 | +9.0% | 736,315 | +21.9% | 0.00% | 0.0% |
| Q2 2021 | $13,291,000 | +12.0% | 604,124 | +21.1% | 0.00% | 0.0% |
| Q1 2021 | $11,869,000 | +8.9% | 498,972 | +19.8% | 0.00% | 0.0% |
| Q4 2020 | $10,898,000 | +48.8% | 416,588 | -1.0% | 0.00% | +100.0% |
| Q3 2020 | $7,325,000 | +6.1% | 420,838 | +2.5% | 0.00% | -50.0% |
| Q2 2020 | $6,904,000 | -30.6% | 410,479 | -50.9% | 0.00% | -33.3% |
| Q1 2020 | $9,943,000 | -31.2% | 836,256 | -29.9% | 0.00% | 0.0% |
| Q4 2019 | $14,444,000 | +2.1% | 1,193,686 | +19.3% | 0.00% | -25.0% |
| Q3 2019 | $14,146,000 | -18.9% | 1,000,854 | -36.0% | 0.00% | -20.0% |
| Q2 2019 | $17,444,000 | +47.0% | 1,564,554 | +54.8% | 0.01% | +66.7% |
| Q1 2019 | $11,867,000 | -39.3% | 1,010,703 | -31.0% | 0.00% | -50.0% |
| Q4 2018 | $19,556,000 | -23.9% | 1,463,835 | -20.1% | 0.01% | 0.0% |
| Q3 2018 | $25,692,000 | +46.0% | 1,832,434 | +63.7% | 0.01% | +20.0% |
| Q2 2018 | $17,599,000 | +36.6% | 1,119,556 | +42.9% | 0.01% | +25.0% |
| Q1 2018 | $12,885,000 | +107.4% | 783,317 | +127.7% | 0.00% | +100.0% |
| Q4 2017 | $6,214,000 | -13.8% | 344,083 | -7.9% | 0.00% | 0.0% |
| Q3 2017 | $7,211,000 | -23.1% | 373,585 | -53.0% | 0.00% | -33.3% |
| Q2 2017 | $9,374,000 | -67.4% | 794,403 | -69.7% | 0.00% | -25.0% |
| Q1 2017 | $28,736,000 | +20.0% | 2,621,794 | -20.5% | 0.00% | 0.0% |
| Q4 2016 | $23,956,000 | +146.9% | 3,299,788 | +121.1% | 0.00% | +33.3% |
| Q3 2016 | $9,702,000 | -14.0% | 1,492,583 | -27.8% | 0.00% | -25.0% |
| Q2 2016 | $11,284,000 | +14.3% | 2,066,721 | -2.1% | 0.00% | 0.0% |
| Q1 2016 | $9,875,000 | -4.2% | 2,110,093 | +1.9% | 0.00% | 0.0% |
| Q4 2015 | $10,313,000 | +27.5% | 2,070,909 | -3.7% | 0.00% | +33.3% |
| Q3 2015 | $8,088,000 | -23.1% | 2,151,238 | +22.9% | 0.00% | -25.0% |
| Q2 2015 | $10,518,000 | +20.0% | 1,750,127 | +11.8% | 0.00% | +33.3% |
| Q1 2015 | $8,765,000 | +99.3% | 1,565,258 | +6.8% | 0.00% | +50.0% |
| Q4 2014 | $4,398,000 | +11.7% | 1,466,200 | -0.2% | 0.00% | 0.0% |
| Q3 2014 | $3,936,000 | -6.1% | 1,468,740 | -1.9% | 0.00% | 0.0% |
| Q2 2014 | $4,192,000 | -35.3% | 1,497,177 | +0.8% | 0.00% | -33.3% |
| Q1 2014 | $6,475,000 | +752.0% | 1,485,214 | +526.6% | 0.00% | – |
| Q4 2013 | $760,000 | +164.8% | 237,041 | +31.4% | 0.00% | – |
| Q3 2013 | $287,000 | +7.5% | 180,345 | +16.8% | 0.00% | – |
| Q2 2013 | $267,000 | – | 154,397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,825,262 | $138,621 | 7.54% |
| Novo Holdings A/S | 3,377,768 | $68,602,468 | 4.28% |
| Parallel Advisors, LLC | 3,724,664 | $75,647,926 | 3.28% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $722 | 2.29% |
| Quantedge Capital Pte Ltd | 251,312 | $5,104,147 | 1.71% |
| S&T BANK/PA | 346,306 | $7,033 | 1.30% |
| Freshford Capital Management, LLC | 249,000 | $5,057,190 | 1.09% |
| Birchview Capital, LP | 50,000 | $1,016 | 0.72% |
| FAS Wealth Partners, Inc. | 306,276 | $6,220,466 | 0.70% |
| Bridge City Capital, LLC | 60,824 | $1,235 | 0.63% |